FDA Inspection
Aragen Life Sciences LimitedAragen Life Sciences Limited – FDA Inspection, May 4, 2018
Record Details
This FDA Inspection record concerns Aragen Life Sciences Limited, with an inspection on May 4, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a9d3f6ce-65df-4457-9697-9d7a0fa010c9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1054180
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Aragen Life Sciences Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 23, 2026 | Not classified | Office of Inspections and Investigations | |
| March 21, 2025 | Not classified | Office of Inspections and Investigations | |
| August 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aragen Life Sciences Limited
- FDA Inspection 1301164 - 2026-01-23
- FDA Inspection 1267657 - 2025-03-21
- FDA Inspection 939499 - 2015-08-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.